419 related articles for article (PubMed ID: 19154261)
1. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
Dundr P; Povýsil C; Tvrdík D
Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
[TBL] [Abstract][Full Text] [Related]
3. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
Nonaka D; Chiriboga L; Rubin BP
J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
[TBL] [Abstract][Full Text] [Related]
5. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
6. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
[TBL] [Abstract][Full Text] [Related]
7. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
8. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas.
Gray MH; Smoller BR; McNutt NS; Hsu A
Arch Dermatol; 1990 Apr; 126(4):472-6. PubMed ID: 1690969
[TBL] [Abstract][Full Text] [Related]
10. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors.
Weiss SW; Langloss JM; Enzinger FM
Lab Invest; 1983 Sep; 49(3):299-308. PubMed ID: 6310227
[TBL] [Abstract][Full Text] [Related]
11. Benign cutaneous neural tumors.
Rodríguez-Peralto JL; Riveiro-Falkenbach E; Carrillo R
Semin Diagn Pathol; 2013 Feb; 30(1):45-57. PubMed ID: 23327729
[TBL] [Abstract][Full Text] [Related]
12. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
13. The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas.
Nascimento AF; Fletcher CD
Am J Surg Pathol; 2007 Sep; 31(9):1363-70. PubMed ID: 17721192
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
[TBL] [Abstract][Full Text] [Related]
15. Expression of cathepsin K in neurofibromatosis 1-associated cutaneous malignant peripheral nerve sheath tumors and neurofibromas.
Yan X; Takahara M; Dugu L; Xie L; Gondo C; Endo M; Oda Y; Nakahara T; Uchi H; Takeuchi S; Tu Y; Moroi Y; Furue M
J Dermatol Sci; 2010 Jun; 58(3):227-9. PubMed ID: 20452751
[No Abstract] [Full Text] [Related]
16. Mediastinal tumors of peripheral nervous system origin.
Marchevsky AM
Semin Diagn Pathol; 1999 Feb; 16(1):65-78. PubMed ID: 10355655
[TBL] [Abstract][Full Text] [Related]
17. The presence of stage II melanosomes (premelanosomes) in neoplasms other than melanomas.
Szpak CA; Shelburne J; Linder J; Klintworth GK
Mod Pathol; 1988 Jan; 1(1):35-43. PubMed ID: 3237689
[TBL] [Abstract][Full Text] [Related]
18. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
19. [Pathologic characteristics of the most frequent peripheral nerve tumors].
Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
